Rainey & Randall Wealth Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Rainey & Randall Wealth Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,563	Closed	-$205K	–	46
2022 Q4	$205K	Sell	1,563 -165	-10%	-$21.3K	0.07%	40
2022 Q3	$202K	Sell	1,728 -3	-0.2%	-$373	0.08%	47
2022 Q2	$204K	Sell	1,731 -2,190	-56%	-$260K	0.08%	47
2022 Q1	$511K	Buy	3,921 +60	+2%	+$7.82K	0.19%	34
2021 Q4	$589K	Buy	3,861 +2,275	+143%	+$352K	0.24%	30
2021 Q3	$256K	Buy	1,586 +67	+4%	+$11.3K	0.12%	48
2021 Q2	$249K	Buy	+1,519	New	+$234K	0.12%	47

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Rainey & Randall Wealth Advisors's IBB Position: Q1 2023 in Review

Rainey & Randall Wealth Advisors sold out of iShares Biotechnology ETF (IBB) in Q1 2023, closing a stake of 1,563 shares — an estimated $205K sold.

Rainey & Randall Wealth Advisors first reported a position in IBB in Q2 2021 and held it in 7 quarters. The position peaked at $589K in Q4 2021. 866 funds tracked by Wall St. Rank hold IBB as of Q1 2023.

Rainey & Randall Wealth Advisors reported no remaining iShares Biotechnology ETF position as of Q1 2023 after selling out during the quarter.
Rainey & Randall Wealth Advisors sold 1,563 iShares Biotechnology ETF shares in Q1 2023, an estimated $205K.
Rainey & Randall Wealth Advisors first reported a position in iShares Biotechnology ETF in Q2 2021 and held it in 7 quarters.
Rainey & Randall Wealth Advisors's iShares Biotechnology ETF position peaked at $589K in Q4 2021.
866 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2023.

Based on Rainey & Randall Wealth Advisors's 13F filing for Q1 2023, filed 24 Apr 2023.